Logo image of MTZ

MASTEC INC (MTZ) Stock Fundamental Analysis

NYSE:MTZ - New York Stock Exchange, Inc. - US5763231090 - Common Stock - Currency: USD

174.75  -3.18 (-1.79%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MTZ. MTZ was compared to 49 industry peers in the Construction & Engineering industry. MTZ has only an average score on both its financial health and profitability. MTZ has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year MTZ was profitable.
MTZ had a positive operating cash flow in the past year.
MTZ had positive earnings in 4 of the past 5 years.
Each year in the past 5 years MTZ had a positive operating cash flow.
MTZ Yearly Net Income VS EBIT VS OCF VS FCFMTZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

1.2 Ratios

With a Return On Assets value of 2.41%, MTZ perfoms like the industry average, outperforming 55.10% of the companies in the same industry.
MTZ has a Return On Equity (7.41%) which is in line with its industry peers.
MTZ has a Return On Invested Capital of 6.92%. This is in the better half of the industry: MTZ outperforms 61.22% of its industry peers.
MTZ had an Average Return On Invested Capital over the past 3 years of 4.07%. This is significantly below the industry average of 16.70%.
The last Return On Invested Capital (6.92%) for MTZ is above the 3 year average (4.07%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.41%
ROE 7.41%
ROIC 6.92%
ROA(3y)0.55%
ROA(5y)2.49%
ROE(3y)1.65%
ROE(5y)6.81%
ROIC(3y)4.07%
ROIC(5y)5.8%
MTZ Yearly ROA, ROE, ROICMTZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

With a Profit Margin value of 1.72%, MTZ perfoms like the industry average, outperforming 44.90% of the companies in the same industry.
MTZ's Profit Margin has declined in the last couple of years.
MTZ's Operating Margin of 4.16% is in line compared to the rest of the industry. MTZ outperforms 44.90% of its industry peers.
MTZ's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 13.13%, MTZ is doing worse than 61.22% of the companies in the same industry.
In the last couple of years the Gross Margin of MTZ has declined.
Industry RankSector Rank
OM 4.16%
PM (TTM) 1.72%
GM 13.13%
OM growth 3Y-13.4%
OM growth 5Y-12.87%
PM growth 3Y-31.6%
PM growth 5Y-24.69%
GM growth 3Y-2.72%
GM growth 5Y-3.06%
MTZ Yearly Profit, Operating, Gross MarginsMTZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

6

2. Health

2.1 Basic Checks

MTZ has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for MTZ remains at a similar level compared to 1 year ago.
MTZ has more shares outstanding than it did 5 years ago.
The debt/assets ratio for MTZ has been reduced compared to a year ago.
MTZ Yearly Shares OutstandingMTZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MTZ Yearly Total Debt VS Total AssetsMTZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

MTZ has an Altman-Z score of 3.46. This indicates that MTZ is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of MTZ (3.46) is better than 67.35% of its industry peers.
The Debt to FCF ratio of MTZ is 2.42, which is a good value as it means it would take MTZ, 2.42 years of fcf income to pay off all of its debts.
MTZ has a Debt to FCF ratio of 2.42. This is in the better half of the industry: MTZ outperforms 73.47% of its industry peers.
A Debt/Equity ratio of 0.71 indicates that MTZ is somewhat dependend on debt financing.
MTZ has a Debt to Equity ratio of 0.71. This is comparable to the rest of the industry: MTZ outperforms 53.06% of its industry peers.
Even though the debt/equity ratio score it not favorable for MTZ, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 2.42
Altman-Z 3.46
ROIC/WACC0.65
WACC10.67%
MTZ Yearly LT Debt VS Equity VS FCFMTZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.22 indicates that MTZ should not have too much problems paying its short term obligations.
MTZ has a Current ratio (1.22) which is comparable to the rest of the industry.
A Quick Ratio of 1.18 indicates that MTZ should not have too much problems paying its short term obligations.
MTZ has a Quick ratio of 1.18. This is comparable to the rest of the industry: MTZ outperforms 46.94% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.18
MTZ Yearly Current Assets VS Current LiabilitesMTZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

MTZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.79%, which is quite impressive.
Measured over the past years, MTZ shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.63% on average per year.
Looking at the last year, MTZ shows a small growth in Revenue. The Revenue has grown by 2.56% in the last year.
Measured over the past years, MTZ shows a quite strong growth in Revenue. The Revenue has been growing by 11.36% on average per year.
EPS 1Y (TTM)107.79%
EPS 3Y-11.15%
EPS 5Y-5.63%
EPS Q2Q%55.21%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y15.66%
Revenue growth 5Y11.36%
Sales Q2Q%19.71%

3.2 Future

Based on estimates for the next years, MTZ will show a very strong growth in Earnings Per Share. The EPS will grow by 24.76% on average per year.
MTZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.69% yearly.
EPS Next Y57.97%
EPS Next 2Y36.12%
EPS Next 3Y29.51%
EPS Next 5Y24.76%
Revenue Next Year11.98%
Revenue Next 2Y10.52%
Revenue Next 3Y9.65%
Revenue Next 5Y7.69%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MTZ Yearly Revenue VS EstimatesMTZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B
MTZ Yearly EPS VS EstimatesMTZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 34.47, MTZ can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of MTZ is on the same level as its industry peers.
MTZ is valuated rather expensively when we compare the Price/Earnings ratio to 27.24, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 24.18, which indicates a rather expensive current valuation of MTZ.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MTZ is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of MTZ to the average of the S&P500 Index (36.42), we can say MTZ is valued slightly cheaper.
Industry RankSector Rank
PE 34.47
Fwd PE 24.18
MTZ Price Earnings VS Forward Price EarningsMTZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

MTZ's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MTZ is cheaper than 61.22% of the companies in the same industry.
81.63% of the companies in the same industry are more expensive than MTZ, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.96
EV/EBITDA 16.04
MTZ Per share dataMTZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MTZ's earnings are expected to grow with 29.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.59
PEG (5Y)N/A
EPS Next 2Y36.12%
EPS Next 3Y29.51%

0

5. Dividend

5.1 Amount

MTZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MASTEC INC

NYSE:MTZ (8/5/2025, 11:28:59 AM)

174.75

-3.18 (-1.79%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-29 2025-10-29/amc
Inst Owners73.54%
Inst Owner Change-0.93%
Ins Owners21.42%
Ins Owner Change1.25%
Market Cap13.79B
Analysts81.82
Price Target185.55 (6.18%)
Short Float %1.96%
Short Ratio1.5
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)32.91%
Min EPS beat(2)16.35%
Max EPS beat(2)49.47%
EPS beat(4)4
Avg EPS beat(4)26.68%
Min EPS beat(4)9.71%
Max EPS beat(4)49.47%
EPS beat(8)7
Avg EPS beat(8)22.85%
EPS beat(12)11
Avg EPS beat(12)16.5%
EPS beat(16)15
Avg EPS beat(16)17.74%
Revenue beat(2)2
Avg Revenue beat(2)2.77%
Min Revenue beat(2)1.55%
Max Revenue beat(2)3.98%
Revenue beat(4)2
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-6%
Max Revenue beat(4)3.98%
Revenue beat(8)3
Avg Revenue beat(8)-3.01%
Revenue beat(12)6
Avg Revenue beat(12)-1.18%
Revenue beat(16)8
Avg Revenue beat(16)-0.84%
PT rev (1m)0.9%
PT rev (3m)12.89%
EPS NQ rev (1m)0.02%
EPS NQ rev (3m)-1.57%
EPS NY rev (1m)0.01%
EPS NY rev (3m)8.3%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)3.68%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)1.88%
Valuation
Industry RankSector Rank
PE 34.47
Fwd PE 24.18
P/S 1.11
P/FCF 14.96
P/OCF 12.62
P/B 4.78
P/tB N/A
EV/EBITDA 16.04
EPS(TTM)5.07
EY2.9%
EPS(NY)7.23
Fwd EY4.14%
FCF(TTM)11.68
FCFY6.68%
OCF(TTM)13.84
OCFY7.92%
SpS157.98
BVpS36.56
TBVpS-0.19
PEG (NY)0.59
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.41%
ROE 7.41%
ROCE 8.71%
ROIC 6.92%
ROICexc 7.35%
ROICexgc 15.22%
OM 4.16%
PM (TTM) 1.72%
GM 13.13%
FCFM 7.39%
ROA(3y)0.55%
ROA(5y)2.49%
ROE(3y)1.65%
ROE(5y)6.81%
ROIC(3y)4.07%
ROIC(5y)5.8%
ROICexc(3y)4.36%
ROICexc(5y)6.31%
ROICexgc(3y)8.75%
ROICexgc(5y)11.72%
ROCE(3y)5.12%
ROCE(5y)7.29%
ROICexcg growth 3Y1.9%
ROICexcg growth 5Y-5.86%
ROICexc growth 3Y-3.57%
ROICexc growth 5Y-10.58%
OM growth 3Y-13.4%
OM growth 5Y-12.87%
PM growth 3Y-31.6%
PM growth 5Y-24.69%
GM growth 3Y-2.72%
GM growth 5Y-3.06%
F-Score7
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 2.42
Debt/EBITDA 2.06
Cap/Depr 35.99%
Cap/Sales 1.37%
Interest Coverage 2.9
Cash Conversion 110.02%
Profit Quality 430.88%
Current Ratio 1.22
Quick Ratio 1.18
Altman-Z 3.46
F-Score7
WACC10.67%
ROIC/WACC0.65
Cap/Depr(3y)37.77%
Cap/Depr(5y)45.07%
Cap/Sales(3y)1.84%
Cap/Sales(5y)2.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.79%
EPS 3Y-11.15%
EPS 5Y-5.63%
EPS Q2Q%55.21%
EPS Next Y57.97%
EPS Next 2Y36.12%
EPS Next 3Y29.51%
EPS Next 5Y24.76%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y15.66%
Revenue growth 5Y11.36%
Sales Q2Q%19.71%
Revenue Next Year11.98%
Revenue Next 2Y10.52%
Revenue Next 3Y9.65%
Revenue Next 5Y7.69%
EBIT growth 1Y96.52%
EBIT growth 3Y0.16%
EBIT growth 5Y-2.97%
EBIT Next Year126.74%
EBIT Next 3Y41.1%
EBIT Next 5Y27.66%
FCF growth 1Y944.67%
FCF growth 3Y16.01%
FCF growth 5Y18.08%
OCF growth 1Y712.68%
OCF growth 3Y12.25%
OCF growth 5Y15.31%